Searchable abstracts of presentations at key conferences in endocrinology

ea0079025 | Abstracts | BES2021

Hypoglycemia after initiation of CFTR modulator therapy in a cystic fibrosis patient without diabetes

Joke Vliebergh , Hakan Bor , Yskout Marie , Lieven Dupont , Natalie Lorent , Bleyenbergh Pascal Van , Pieter Gillard , der Schueren Bart Van , Ann Mertens , Chantal Mathieu , Roman Vangoitsenhoven

Background: Cystic fibrosis (CF) is a genetic disorder in which a dysfunctional cystic fibrosis transmembrane regulator (CFTR) chloride channel can result in multimorbidity, including severe respiratory disease and reduced pancreatic exocrine secretion and diabetes. Recently, CFTR modulator therapy, has emerged with the potential of improving respiratory function and remission of diabetes. The effect of CFTR modulator therapy on pancreatic function in patients without preexist...